171 related articles for article (PubMed ID: 23717719)
21. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
22. [Sulfadoxine-pyrimethamine-based intermittent preventive treatment in pregnant women and its effect on birth weight: application of 3-dosing regimen in the urban area of South Benin in 2017].
Biaou COA; Kpozehouen A; Glèlè-Ahanhanzo Y; Ayivi-Vinz G; Ouro-Koura AR; Azandjèmé C
Pan Afr Med J; 2019; 34():155. PubMed ID: 32153695
[TBL] [Abstract][Full Text] [Related]
23. Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective.
Nosten F; McGready R
Malar J; 2015 Jun; 14():248. PubMed ID: 26088554
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso.
Müller O; Traore C; Kouyate B
Malar J; 2004 May; 3():10. PubMed ID: 15134583
[TBL] [Abstract][Full Text] [Related]
25. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
[TBL] [Abstract][Full Text] [Related]
26. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis.
Roh ME; Kuile FOT; Rerolle F; Glymour MM; Shiboski S; Gosling R; Gutman J; Kakuru A; Desai M; Kajubi R; L'Ianziva A; Kamya MR; Dorsey G; Chico RM
Lancet Glob Health; 2020 Jul; 8(7):e942-e953. PubMed ID: 32562650
[TBL] [Abstract][Full Text] [Related]
27. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
ter Kuile FO; van Eijk AM; Filler SJ
JAMA; 2007 Jun; 297(23):2603-16. PubMed ID: 17579229
[TBL] [Abstract][Full Text] [Related]
28. [Change of antimalarial first-line treatment in Burkina Faso in 2005].
Gansané A; Nébié I; Soulama I; Tiono A; Diarra A; Konaté AT; Ouédraogo A; Sirima BS
Bull Soc Pathol Exot; 2009 Feb; 102(1):31-5. PubMed ID: 19343918
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
Maiga AS; Diakite M; Diawara A; Sango HA; Coulibaly CO
Mali Med; 2010; 25(3):41-8. PubMed ID: 21441083
[TBL] [Abstract][Full Text] [Related]
30. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
[TBL] [Abstract][Full Text] [Related]
31. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
[TBL] [Abstract][Full Text] [Related]
32. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
[TBL] [Abstract][Full Text] [Related]
33. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
[TBL] [Abstract][Full Text] [Related]
34. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
[TBL] [Abstract][Full Text] [Related]
35. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
Mbonye AK; Yanow S; Birungi J; Magnussen P
BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
[TBL] [Abstract][Full Text] [Related]
36. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Cisse M; Sangare I; Lougue G; Bamba S; Bayane D; Guiguemde RT
BMC Infect Dis; 2014 Nov; 14():631. PubMed ID: 25408152
[TBL] [Abstract][Full Text] [Related]
38. Compliance with intermittent preventive treatment during pregnancy among postpartum women in Ibadan, Nigeria.
Oluwatosin OA; Aluko JO
Afr J Med Med Sci; 2014 Mar; 43(1):67-74. PubMed ID: 25335380
[TBL] [Abstract][Full Text] [Related]
39. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
[TBL] [Abstract][Full Text] [Related]
40. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
